A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors - Concepedia

Concepedia

Publication | Closed Access

A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors

19

Citations

26

References

2009

Year

Robert A. Chase, Angela Skelton, Ellen Xia, Stephanie Curry, Shaotang Liu, Patricia McMonagle, Hsiao‐Ching Huang, Xiao Tong

Antiviral Research

Molecular VirologyPathogenesisImmunologyAntiviral Drug DevelopmentProtease Inhibitor BoceprevirVirologyCombination TreatmentAntiviral TherapyNs5b Polymerase InhibitorsAntiviral DrugMedicine

References

	Year	Citations

Page 1

Page 1